Investor Presentaiton

1 Specialty Pharmaceuticals Leading Market Positions Across Business Lines, with High Barriers To Entry For Specialty Pharmaceuticals Radio pharma Allergy Therapy Products CMO Highlights #3 radiopharmaceuticals manufacturer in the US (1) #2 commercial radiopharmacy network in the US (1) Specialists in lung, thyroid, bone and cardiac imaging products ✓ Sole supplier with 100% market share in the US in MAA and DTPA (1) ✓ Currently the only FDA approved supplier of I-131 (Thyroid) in the market ✓ Received two 505(b)(2) approvals for RUBYFILL® and DraxImage Exametazime #2 player in the allergenic extract market in the US (1) Product range of 200+ different allergenic extracts, six insect venom products and exclusive skin diagnostic testing devices Sole producer and supplier of venom products in the US(1) Serves 7 out of the top 20 pharmaceuticals companies globally based on revenue (1) Deep and long-term relationships with our top 10 customers ✓ At least 10 years of business relationships with 6 of our top 10 customers Entry Barriers Extensive regulatory and licensing requirements Capital intensive nature of the business Vertical Integration with commercial radiopharmacy business Biotechnology products with grandfather status; new products require an NDA Niche US allergen extract market Limited number of manufacturers with the requisite know- how for sterile injectables Proximity to customers Technical expertise required to develop products, obtain licensing and regulatory approvals LSI Generics CDMO APIS Solid Dosage Formulations One of the market leaders in the US for several key API products Oxcarbazepine (global market share at c.30%) Carbamazepine (global market share at c.20%) and others 55 products across the, US, Europe, Canada, Australia and the rest of the world (2) #1 player in 4 products with over 45% share in each of the three products Amongst top 3 players in another 2 products Speciality Intermediates and Global leadership position in Pyridines & derivatives Second largest producer globally in Vitamin B3 Leader in 11 fine ingredients products Nutritional Products Life Science Chemicals Globally top 4 in Acetic Anhydride (Merchant Sales) Globally #7 in Ethyl Acetate (1) According to Frost & Sullivan - Independent Market Research on the Radiopharmaceutical Industry, US Radiopharmacy Chain, US Contract Manufacturing Organisation Industry, US Allergy Immuno Therapy Industry and the Global and US Generic Pharmaceutical Industry; (2) As of June 30, 2019 JUBILANT PHARMA

View entire presentation